Copyright: ©Author(s) 2027.
World J Gastroenterol. Jan 7, 2027; 33(1): 123034
Published online Jan 7, 2027. doi: 10.3748/wjg.123034
Published online Jan 7, 2027. doi: 10.3748/wjg.123034
Table 1 Orthogonal least partial squares discriminant analysis model parameters
| Model | Group | R2Y value | Q2 value | ||||
| Serum | Liver | Urine | Serum | Liver | Urine | ||
| ESI+ | CON vs MOD | 0.998 | 0.998 | 0.998 | 0.777 | 0.866 | 0.968 |
| FZD vs MOD | 0.997 | 0.994 | 0.997 | 0.799 | 0.412 | 0.962 | |
| ESI- | CON vs MOD | 0.998 | 0.992 | 0.993 | 0.873 | 0.882 | 0.962 |
| FZD vs MOD | 0.999 | 0.998 | 0.998 | 0.906 | 0.576 | 0.979 | |
Table 2 Fuling Zexie decoction-derived compounds in serum of rats with metabolic dysfunction-associated steatotic liver disease
| tR (minute) | [M+H]+ [M+Na]+ m/z | ESI-MSn (+) m/z | [M-H]- m/z | ESI-MSn (-) m/z | Predicted formula | Predicted (m/z) | Measured (m/z) | Diff (ppm) | Assigned identification | Source | Type |
| 1.572 | 118.0864 | 118.0854 | C5H11NO2 | 118.0863 | 118.0864 | 0.85 | Betaine | AMR | Alkaloid | ||
| 2.729 | 263.1673 | 263.878, 163.1489, 145.0991, 117.0701 | C16H22O3 | 263.1649 | 263.1673 | 9.12 | 8beta-Methoxyatractylenolide I | AMR | Sesquiterpenoids | ||
| 3.091 | 133.0648 | 105.0697, 115.0542 | C9H8O | 133.0647 | 133.0648 | 0.75 | Trans-cinnamaldehyde | CR | Aromatic aldehydes | ||
| 3.195 | 119.0350 | 119.0863 | C4H6O4 | 119.0339 | 119.0350 | 9.24 | Succinic acid | CR | Aliphatic dicarboxylic acids | ||
| 3.352 | 149.0595 | 130.9506, 119.9283, 103.944, 102.9436 | C9H8O2 | 149.0597 | 149.0595 | -1.34 | Cinnamic acid | CR | Aromatic carboxylic acids | ||
| 5.184 | 217.1585 | 217.0204, 199.0299, 189.0469, 175.0313, 161.018, 119.0869, 107.0496 | C15H20O | 217.1587 | 217.1585 | -0.92 | Atractylone | AMR | Sesquiterpenoids | ||
| 7.496 | 475.3741 | 457.3129 | C30H50O4 | 475.3782 | 475.3741 | -8.62 | 11-deoxyalisol A | AR | Triterpenoids | ||
| 8.113 | 455.3501 | 295.1916 | C30H46O3 | 455.352 | 455.3501 | -4.17 | Dehydrotrametenolic acid | PR | Triterpenoids | ||
| 10.392 | 433.1126 | 416.8033, 398.7295, 367.146, 323.2313, 165.1012 | C21H20O10 | 433.1129 | 433.1126 | -0.69 | Vitexin | GRR | Flavonol glycosides | ||
| 10.401 | 433.1134 | 257.0902, 239.0705, 137.0232 | C21H20O10 | 433.1129 | 433.1134 | 1.15 | Liquiritigenin-4-O-glucuronide | GRR | Flavanone glycosides | ||
| 11.530 | 271.0964 | 148.9916 | C16H14O4 | 271.0965 | 271.0964 | -0.37 | 4,4’-dihydroxy-2-methoxychalcone | GRR | Chalcones | ||
| 11.834 | 277.1800 | 259.5875, 189.0878 | C17H24O3 | 277.1798 | 277.1800 | 0.72 | 6-Shogaol | ZRR | Shogaols | ||
| 12.867 | 163.0393 | 163.1483, 135.0831, 107.0865 | C9H6O3 | 163.039 | 163.0393 | 1.84 | 7-Hydroxycoumarin | AMR | Coumarins | ||
| 13.118 | 347.2215 | 177.1277, 137.0955 | C21H30O4 | 347.2217 | 347.2215 | -0.58 | 1-Dehydro-[10]-gingerdione | ZRR | Dehydrogingerdiones | ||
| 13.3 | 429.1734 | 295.1494, 163.1091 | C20H28O10 | 429.1755 | 429.1734 | -4.89 | Cinnamylalcohol-6’-o-α-furanara-binose-O-β-glucopyranoside | CR | Aromatic alcohol glycosides | ||
| 14.149 | 233.1538 | 233.1524, 205.0327, 189.0586, 159.0813, 145.0636, 133.1017, 131.0857, 105.0699 | C15H20O2 | 233.1536 | 233.1538 | 0.86 | Atractylenolide II | AMR | Sesquiterpenoids | ||
| 16.872 | 415.3211 | 157.0082, 143.0864, 129.0775, 105.0696 | C27H42O3 | 415.3207 | 415.3211 | 0.96 | Diosgenin | AMR | Steroids | ||
| 18.027 | 231.1380 | 231.0799, 189.0884, 161.0607, 128.0625, 105.0311 | C15H18O2 | 231.138 | 231.1380 | 0.00 | Atractylenolide Ι | AMR | Sesquiterpenoids | ||
| 18.314 | 469.3314 | 391.0493 | C30H44O4 | 469.3312 | 469.3314 | 0.43 | 3-oxo-16α-hydroxylanosta-7, 9(11), 24-trien-21-oic acid | PR | Triterpenoids | ||
| 18.314 | 469.3314 | 471.2854, 337.0586 | C30H44O4 | 469.3312 | 469.3314 | 0.43 | Alisol L | AR | Triterpenoids | ||
| 27.023 | 471.3465 | 453.336, 435.3262, 425.3419 | C30H46O4 | 471.3469 | 471.3465 | -0.85 | 16α-hydroxydehydrotrametenolic acid | PR | Triterpenoids | ||
| 27.084 | 453.3363 | 435.3329, 339.2752 | C30H44O3 | 453.3363 | 453.3363 | 0.00 | Dehydrotrametenonic acid | PR | Triterpenoids | ||
| 27.627 | 471.3467 | 471.3462, 453.3377 | C30H46O4 | 471.3469 | 471.3467 | -0.42 | 16,23-oxidoalisol B | AR | Triterpenoids | ||
| 28.744 | 471.3474 | 453.3377, 189.1636 | C30H46O4 | 471.3469 | 471.3474 | 1.06 | Glycyrrhetinic acid | GRR | Triterpenoids | ||
| 28.849 | 203.1792 | 161.0607, 105.0697 | C15H22 | 203.1794 | 203.1792 | -0.98 | Atractylenolide VI | AMR | Sesquiterpenoids | ||
| 33.482 | 293.1774 | 155.0371, 112.9707 | C17H24O4 | 293.1747 | 293.1774 | 9.21 | [6]-gingerdione | ZRR | Gingerdiones | ||
| 33.962 | 331.2841 | 331.2614 | C19H38O4 | 331.2843 | 331.2841 | -0.60 | 2-monopalmitin | AMR | Monoacylglycerols | ||
| 34.949 | 319.1932 | 151.0802 | C19H26O4 | 319.1904 | 319.1932 | 8.77 | 1-dehydro-[8]-gingerdione | ZRR | Gingerdiones | ||
| 35.241 | 531.3684 | 167.1446 | C32H50O6 | 531.3680 | 531.3684 | 0.75 | 3-O-acetyl-16α, 26-dihydroxytrametenolic acid | PR | Triterpenoids | ||
| 4.398 | 167.0352 | 167.0228, 123.0091 | C8H8O4 | 167.035 | 167.0352 | 1.20 | Vanillic acid | CR | Phenolic acids | ||
| 7.341 | 499.3416 | 437.1592, 421.3151 | C31H48O5 | 499.3429 | 499.3416 | -2.60 | 16α, 25-dihydroxyeburiconic acid | PR | Triterpenoids | ||
| 8.385 | 255.0665 | 237.2247, 135.7461 | C15H12O4 | 255.0663 | 255.0665 | 0.78 | Liquiritigenin | GRR | Flavanones | ||
| 13.728 | 281.1395 | 281.2485, 263.238, 245.2271 | C15H22O5 | 281.1394 | 281.1395 | 0.36 | 4, 6-dihydroxy-3, 3a-dihydro atractylenolide III | AMR | Sesquiterpenoids | ||
| 17.552 | 469.3658 | 339.2162 | C31H50O3 | 469.3687 | 469.3658 | -6.18 | Eburcoic acid | PR | Triterpenoids | ||
| 17.792 | 499.3066 | 367.1447 | C30H44O6 | 499.3065 | 499.3066 | 0.20 | 3-oxo-16-oxo-11-anhydroalisol A | AR | Triterpenoids | ||
| 18.757 | 487.3426 | 453.279, 435.0019, 381.019 | C30H48O5 | 487.3429 | 487.3426 | -0.62 | Alisol F | AR | Triterpenoids | ||
| 25.201 | 497.3272 | 423.8392, 379.2716 | C31H46O5 | 497.3272 | 497.3272 | 0.00 | Poricoic acid A | PR | Triterpenoids | ||
| 34.320 | 347.2204 | 211.843 | C21H32O4 | 347.2227 | 347.2204 | -6.62 | 10-gingerdione | ZRR | Gingerdiones | ||
| 35.423 | 531.3683 | 309.2785, 391.1912 | C32H50O6 | 531.368 | 531.3683 | 0.56 | Alisol F-24-acetate | AR | Triterpenoids |
Table 3 Docking information between Fuling Zexie decoction-derived key compounds and core targets
| Component | Target | Binding-energy (kcal/mol) | Amino acid residues |
| 8beta-Methoxyatractylenolide I | PLA2G2A | -5.2 | Gly-32 |
| Liquiritigenin | PLA2G2A | -6.1 | Lys-62 |
| Atractylenolide II | MAOA | -9 | Ile-325, Ile-335, Ile-180, Phe-208, Phe-352, Leu-337, and Glu-216 |
| 7-Hydroxycoumarin | MAOA | -7.8 | Val-244, Leu-277, and Ala-44 |
| [6]-gingerdione | MAOA | -7.9 | Glu-216, Tyr-407 |
| 4,4’-Dihydroxy-2-methoxychalcone | MAOA | -9.3 | Glu-43, Ala-44, and Arg-51 |
| 1-Dehydro-[8]-gingerdione | MAOA | -8.9 | Val-244, Glu-43, Arg-45, Gly-21, and Gly-22 |
| 1-Dehydro-[10]-gingerdione | MAOA | -8.1 | Tyr-444 |
| Atractylenolide II | MPO | -5.1 | Glu-181 |
| 7-Hydroxycoumarin | XDH | -5.8 | Arg-1053, Ser-1185, and Gln-562 |
| 7-Hydroxycoumarin | MIF | -8 | Asn-97, Ile-64, and Lys-32 |
| [6]-gingerdione | MIF | -7.1 | Tyr-36, Tyr-95, Lys-32, and Pro-1 |
| 6-Shogaol | MIF | -6.8 | Lys-32, Asn-97 |
| Dehydrotrametenonic acid | MIF | -4.7 | Pro-15, Glu-21 |
| 1-dehydro-[8]-gingerdione | MIF | -6.3 | His-40, His-62, Asn-97, and Tyr-99 |
| 1-dehydro-[10]-gingerdione | MIF | -6.1 | Tyr-99, His-62, Ser-60, and Asn-6 |
| 10-gingerdione | MIF | -6.5 | Tyr-99, His-62 |
| 7-Hydroxycoumarin | CYP1A2 | -8.8 | Gly-316, Asp-313 |
| [6]-gingerdione | CYP1A2 | -7.8 | Thr-124 |
| 7-Hydroxycoumarin | ALDH2 | -5.9 | Arg-329 |
| 6-Shogaol | ALDH2 | -7.3 | Asp-457, Gln-289 |
| 10-gingerdione | ALDH2 | -8.8 | Leu-269, Trp-168 |
| 7-Hydroxycoumarin | ACHE | -7.6 | His-447 |
| [6]-gingerdione | ACHE | -8.1 | Ser-125, Tyr-124, Gly-121, and Ser-203 |
| 4,4’-dihydroxy-2-methoxychalcone | ACHE | -10.0 | His-447, Tyr-341 |
| Liquiritigenin | ACHE | -9.6 | Trp-86, Gly-121, Gly-122, and Ser-203 |
| Eburcoic acid | ACHE | -9.2 | Phe-295 |
| 16,23-oxidoalisol B | NOS2 | -11.2 | Arg-381 |
| Alisol F-24-acetate | NOS2 | -9.3 | Trp-463, Tyr-491, Phe-369, Trp-194, and Ile-201 |
| Trans-cinnamaldehyde | NOS2 | -7.5 | Phe-369, Leu-209, and Trp-194 |
| Glycyrrhetinic acid | NOS2 | -8.9 | Lys-497 |
| 4,4’-dihydroxy-2-methoxychalcone | NOS2 | -9.5 | Trp-372, Tyr-489 |
| Dehydrotrametenonic acid | NOS2 | -10 | Trp-372 |
| Eburcoic acid | NOS2 | -10 | Trp-372 |
| 16α, 25-dihydroxyeburiconic acid | NOS2 | -10 | Arg-381 |
| Dehydrotrametenolic acid | NOS2 | -9.8 | Trp-461, Ile-462, Phe-476, Trp-463, and Ile-201 |
| 16α-hydroxydehydrotrametenolic acid | NOS2 | -10.2 | Arg-381, Val-465 |
| 11-deoxyalisol A | NOS2 | -9.1 | E377, Y347 |
| Alisol F-24-acetate | GSTM1 | -6.4 | Trp-7, Leu-59, and Asn-58 |
| Alisol F | TKT | -8.5 | Gln-290, Lys-144, Lys-140, and Lys-232 |
| Trans-cinnamaldehyde | ADH4 | -6 | Phe-325, Tyr-95, and Thr-184 |
| Cinnamic acid | MAOB | -7.5 | Gly-12, Gly-13, and Arg-36 |
| 4,4’-dihydroxy-2-methoxychalcone | MAOB | -10.1 | Thr-196 |
| Liquiritigenin | MAOB | -9.1 | Gly-434 |
| 6-Shogaol | GSTP1 | -5.6 | Arg-70, Asp-94, Arg-70, Asn-66, and Gln-64 |
| Dehydrotrametenonic acid | PLA2G4A | -5.6 | Asp-99, Arg-59, and Asp-55 |
| Poricoic acid A | PLA2G4A | -4.8 | Thr-104, Thr-90, and Arg-59 |
| 16α-hydroxydehydrotrametenolic acid | PLA2G4A | -5.8 | Asp-55, Lys-58 |
| Betaine | GOT1 | -4 | Gly-109, Ser-258, and Ala-110 |
| Betaine | GOT2 | -3.5 | Ser-118, Glu-119 |
- Citation: Wang PQ, Yang H, Tang YM, Tao YX, Han SC, Zhou QD, Yu J, Yang XX. Mechanisms of Fuling Zexie decoction against metabolic dysfunction-associated steatotic liver disease: Integrative metabolomics, gut microbiota and serum pharmacochemistry. World J Gastroenterol 2027; 33(1): 123034
- URL: https://www.wjgnet.com/1007-9327/full/v33/i1/123034.htm
- DOI: https://dx.doi.org/10.3748/wjg.123034